コンテンツへ移動
Evolution-adjusted tumor pathophysiology: the novel language of tumor biology 資料のプレビュー
閉じる資料のプレビュー
確認中…

Evolution-adjusted tumor pathophysiology: the novel language of tumor biology

著者: Albrecht Reichle
出版: Dordrecht ; New York : Springer, ©2013.
エディション/フォーマット:   電子書籍 : Document : Englishすべてのエディションとフォーマットを見る
データベース:WorldCat
概要:

Evolution-adjusted Tumor Pathophysiology

評価:

(まだ評価がありません) 0 件のレビュー - 是非あなたから!

件名:
関連情報:

 

オンラインで入手

この資料へのリンク

オフラインで入手

&AllPage.SpinnerRetrieving; この資料の所蔵館を検索中…

詳細

ジャンル/形式: Electronic books
資料の種類: Document, インターネット資料
ドキュメントの種類: インターネットリソース, コンピューターファイル
すべての著者/寄与者: Albrecht Reichle
ISBN: 9789400768666 9400768664
OCLC No.: 852664238
注記: Includes index.
物理形態: 1 online resource.
コンテンツ: Preface. I Introduction. 1. Communication a" evolution a" pathophysiology: An endogenous conjunction a"Instead of an introduction. II Combined modularized therapies for metastatic tumors: Pointing to central problems of communication among 'systems participators' in tumors. 2 Applied systems biology for the control of metastatic cancer: Therapeutic top-down strategy for targeting the tumors' normativity. 3 Targeting the proangiogenic network in angiosarcomas: Biomodulatory therapy.4 Long-term results of combined modularized, immune-modulatory, angiostatic, and antiinflammatory therapy in systemically pre-treated multi-systems Langerhans cell histiocytosis. 5 Redirecting and modulating rationalizations of tumor-immanent normative functions in castration-resistant prostate ancer. III Social engineering: Biomodulation, either endogenously initiated or by implementation of non-normative boundary conditions. 6 Non-hierarchically organized operations in malignancies: Stromal dysfunction induces hematopoetic malignancies. 7 Biomodulatory therapy approaches in renal clear cell carcinoma: A perspective. 8 Proteome analysis identified the PPARc ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interaction.IV The tumors' normativity: Reconstructing and operationalizing starting points for an evolution theory. 9 The philosophical quest of a cancer cell: Redefining existentialism. 10 The tumor's normativity: Normative structures, action norms and decision maxims as therapeutic targets for tumor therapy. 11 Criticizable claims for the validity of communication acts in biological systems: Therapeutic implications in cancer. V Evolution theory. 12 Evolution theory: Its practical relevance for understanding tumor development and specifying tumor therapy. 13 Modularity, subjectivity, intersubjectivity and normativity: Clinically applicable operative benchmarks.14 Turning upside down the mode of science to emphasize and harness the impact of environmental communicative events. VI From genome- or organ-centric to rationalization-centric systematization of tumors. 15 Purposive-rational tumor therapy: Exploiting the tumor's 'living world' for diversifying, specifying and personalizing tumor therapy. 16 Including rationalizations of tumor-associated normative notions in pathophysiologic considerations: Communication-theoretical implications.VII Reconstruction of tumor-immanent normative functions, structures and decision maxims (hubs). 17 Bridging a diagnostic and therapeutic gap: Selecting, assessing and categorizing tumor-associated normative notions. 18 Personalizing tumor pathophysiology by diagnosing developmental problems in tumors with imaging techniques. 19 Biologic memory: Induction by metronomically administered combined modularized therapy. VIII The tool of rationalizations constituting tumor-associated normative notions: The non-genomic counterpart of the tumor genome and therefore, an important therapeutic target for diversifying palliative care. 20 Diversifying and specifying palliative care for patients with metastatic cancer by therapeutic implementation of non-normative boundary conditions. 21 Targeting a hallmark of cancer: Simultaneous inflammation and tumor control for palliative care in metastatic cancer. IX Novel clinical and pharmaceutical technology for bioengineering tumor response. 22 Combined modularized tumor therapy a" tumor biology a" and prognostic factors: Bioengineering tumor response. X Objectifying the systems objects' subjectivity in biological systems: A novel reification of the scientific picture about the 'objective' world. 23 The systems objects' subjectivity as scientific object. Index.
責任者: Albrecht Reichle, editor.
その他の情報:

レビュー

ユーザーレビュー
GoodReadsのレビューを取得中…
DOGObooksのレビューを取得中…

タグ

まずはあなたから!
リクエストの確認

あなたは既にこの資料をリクエストしている可能性があります。このリクエストを続行してよろしければ、OK を選択してください。

リンクデータ


<http://www.worldcat.org/oclc/852664238>
library:oclcnum"852664238"
library:placeOfPublication
library:placeOfPublication
library:placeOfPublication
owl:sameAs<info:oclcnum/852664238>
rdf:typeschema:Book
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:bookFormatschema:EBook
schema:contributor
schema:copyrightYear"2013"
schema:datePublished"2013"
schema:exampleOfWork<http://worldcat.org/entity/work/id/1401855909>
schema:genre"Electronic books."
schema:inLanguage"en"
schema:name"Evolution-adjusted tumor pathophysiology: the novel language of tumor biology"
schema:publisher
schema:url<http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=604820>
schema:url<http://dx.doi.org/10.1007/978-94-007-6866-6>
schema:url
schema:url<http://lib.myilibrary.com?id=518952>
schema:workExample

Content-negotiable representations

ウインドウを閉じる

WorldCatにログインしてください 

アカウントをお持ちではないですか?簡単に 無料アカウントを作成することができます。.